Filing Details

Accession Number:
0001948079-23-000001
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-01-06 13:03:16
Reporting Period:
2023-01-04
Accepted Time:
2023-01-06 13:03:16
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1907685 Comera Life Sciences Holdings Inc. CMRA Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1948079 David Soane C/O Soane Labs, Llc
380 Ne 72Nd Terrace
Miami FL 33138
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-01-04 67,567 $1.23 3,336,562 No 4 P Indirect By Trust
Common Stock Acquisiton 2023-01-04 67,567 $1.23 88,729 No 4 P Indirect By Trust
Common Stock Acquisiton 2023-01-04 67,567 $1.23 88,729 No 4 P Indirect By Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Trust
No 4 P Indirect By Trust
No 4 P Indirect By Trust
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Warrant (right to buy) Acquisiton 2023-01-04 135,134 $0.13 135,134 $1.23
Common Stock Warrant (right to buy) Acquisiton 2023-01-04 135,134 $0.13 135,134 $1.23
Common Stock Warrant (right to buy) Acquisiton 2023-01-04 135,134 $0.13 135,134 $1.23
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
135,134 2023-01-04 2028-01-04 No 4 P Indirect
135,134 2023-01-04 2028-01-04 No 4 P Indirect
135,134 2023-01-04 2028-01-04 No 4 P Indirect
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 589,786 Direct
Footnotes
  1. Includes 663,288 Earn-Out Shares. Earn-Out Shares are shares of Common Stock held in escrow, which shares will be released if, at any time prior to May 19, 2024, either (i) the volume-weighted average price of the Common Stock is equal to or greater than $12.50 for twenty trading days within a thirty trading day period or (ii) upon a change of control with aggregate consideration in excess of $12.50 per share of Common Stock.
  2. Held by The Soane Family Trust, of which David Soane is a trustee and members of the Dr. Soane's immediate family are trustees and beneficiaries. Dr. Soane disclaims beneficial ownership except to the extent of his pecuniary interest therein and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purposes
  3. Includes 4,298 Earn-Out Shares
  4. Held by the Alexander V. Soane 2019 Irrevocable Trust. Members of David Soane's immediate family serve as trustee and are beneficiaries of such trusts. The reporting persons disclaim beneficial ownership except to the extent of their pecuniary interest therein and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purposes
  5. Held by the Nicholas V. Soane 2019 Irrevocable Trust. Members of David Soane's immediate family serve as trustee and are beneficiaries of such trusts. The reporting persons disclaim beneficial ownership except to the extent of their pecuniary interest therein and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purposes
  6. Includes 119,779 Earn-Out Shares